Skip to content

Prospective clinical study to evaluate the success and survival of two-piece zirconia Hexalobe implants: A single center study

Prospective clinical study to evaluate the success and survival of two-piece zirconia Hexalobe implants: A single center study - Ceramic Implants

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00012469
Enrollment
24
Registered
2017-06-23
Start date
2017-10-19
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

K08.1

Interventions

Group 1: Single tooth restoration with a ceramic two-piece implant system and a single crown.

Sponsors

Charité Centrum Zahn-, Mund- und Kieferheilkunde, Zahnärztliche Prothetik, Alterszahnmedizin und Funktionslehre
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Males and females with at least 18 years of age. - Single tooth gaps at least 7.5 mm wide in maxilla or mandible (#1-#7 FDI) allowing the placement of a single implant. Adjacent mesial and distal tooth must be natural tooth. - Adequate bone quality and quantity at the implant site to permit the insertion of a zirconia implant. - Opposing dentition must be natural teeth or fixed restoration. - If patient undergo a large bone augmentation (with autogenous bone block) a delay of 3.5 months must elapse before implantation. - Patient has been informed of the follow-up visits and is willing to return to the clinical center for these follow-up visits.

Exclusion criteria

Exclusion criteria: - Free-end situations - Systemic disease that would interfere with dental implant therapy (e.g. uncontrolled diabetes) - Patients who smoke >10 cigarettes per day or cigar equivalents, or who chew tobacco - Cardiovascular disease - Coagulation disorders (including taking anticoagulants) - Metabolic bone disease - Chemotherapy or radiation treatment - Chronic inflammation - Metabolic or systemic disorders associated with lesions and/or bone healing - The use of pharmaceutical products that block or modify bone healing - Uncontrolled para-functional diseases (bruxism, clenching or grinding of teeth) - Insufficient inter-arc gap - Intraoral infection - Insufficient coverage of the soft tissue - Disorders that impede the ability of patients to maintain adequate oral hygiene - Conditions or circumstances, in the opinion of the investigator, which would prevent completion of study participation or interfere with analysis of study results, such as history of non-compliance or unreliability

Design outcomes

Primary

MeasureTime frame
Implant survival and success at 12 months post-loading. Success criteria according to Buser and the use or radiographs. Evaluation of any complications and adverse events.

Secondary

MeasureTime frame
Change in bone level, changes in soft tissue, aesthetical outcome, patient satisfaction - all at 6, 12, 18, 24, 36, 48, 60 months post-loading and all by evaluating the following parameters: -mesial/distal bone contact at implant (radiograph) -Papilla score (Jemt) - Soft tissue recession (Grunder) - Pink and White esthetic score (Belser) - Volume of soft tissue (intra-oral scan) - Plaque assessment (PPI) - Bleeding on probing (BOP) - Modified gingival index (MGI) - Porbing pocket depths (PPD) - Width of the keratinized mucosa (KM) - Matrix-metalloproteinase 8 (immunology) - Patient satisfaction (PROMs)

Countries

Germany

Contacts

Public ContactFlorian Beuer

Charité Centrum Zahn-, Mund- und Kieferheilkunde, Zahnärztliche Prothetik, Alterszahnmedizin und Funktionslehre

florian.beuer@charite.de+49 304 5056 2701

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026